Iga Swiatek case, Simona Halep complains of unequal treatment

Iga Swiatek case, Simona Halep complains about disparityà treatment

"Whyé such a great disparityà of treatment? ". Soì l'former women’s tennis No. 1 Simona Halep in a long post on her Instagram profile commented on the one-month disqualification for Iga Swiatek, now world No. 2, who tested positive for trimetazidine (Tmz).

Itia, the agency responsible for enforcing the anti-doping program in tennis, accepted the defense argument of contamination of a batch of melatonin tablets. Halep, on the other hand, è was provisionally suspended until October 2022 and then è was disqualified for four years for a double positive test for roxadustat.

The penalty è was later reduced to nine months last March after the Romanian appealed to the Court of Arbitration for Sport in Lausanne. "I don’t find and don’t think there is a logical answer to explain the difference in treatment. I can only think of a bad willà of the'Itia, the organization that did everything to destroy me despite the evidence" said Halep.

The Swiatek affair however cannot be said to be over. Wada and the Polish anti-doping agency may appeal to the Tas, in fact, and initiate a second verdict on the positivity to trimetazidine, a substance used in the treatment of cardiovascular diseases such as angina pectoris, which is on the list of prohibited substances among hormonal and metabolic regulators. Although toxicologist Pascal Kintz pointed out in 2022, as reported by Equipe, how there was no description of doping effects of trimetazidine in the medical literature.